loading page

Cervical cancer brachytherapy amid the COVID-19 pandemic: A single institutional case series
  • +2
  • Zahra Siavashpour,
  • Mahdi Aghili,
  • Ramin Jaberi,
  • Anya Jafari,
  • Fatemeh Jafari
Zahra Siavashpour
Shahid Beheshti University of Medical Sciences
Author Profile
Mahdi Aghili
Tehran University of Medical Sciences School of Medicine
Author Profile
Ramin Jaberi
Tehran University of Medical Sciences
Author Profile
Anya Jafari
Shahid Beheshti University of Medical Sciences
Author Profile
Fatemeh Jafari
Tehran University of Medical Sciences
Author Profile

Abstract

Dose escalation to target volume during High Dose Rate brachytherapy was effectively employed to treat locally advanced cervical cancer patients who experienced prolongation of overall treatment time (OTT) due to the COVID-19 pandemic. It was tried to achieve acceptable oncological outcomesÙˆ while respecting the dose constraints of organs at risk.